# Genesis Energy LP: financial statements, quarterly

GEL · NYSE · CIK 1022321 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gel.md) · [Financials](/companies/gel/financials.md) · [Filings](/companies/gel/filings.md) · [Insiders](/companies/gel/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gel/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [808](/filings/0001022321-24-000095.md) | [(682) d](/filings/0001022321-26-000008.md) | [434](/filings/0001022321-25-000047.md) | [430](/filings/0001022321-25-000055.md) | [397](/filings/0001022321-25-000062.md) | [399 d](/filings/0001022321-26-000008.md) | [398](/filings/0001022321-26-000017.md) | [377](/filings/0001022321-26-000023.md) | [414](/filings/0001022321-25-000062.md) | [441 d](/filings/0001022321-26-000008.md) | [447](/filings/0001022321-26-000017.md) | [532](/filings/0001022321-26-000023.md) |
| Operating income | $m | [112](/filings/0001022321-24-000095.md) | [(58.7) d](/filings/0001022321-26-000008.md) | [58.1](/filings/0001022321-25-000047.md) | [49.8](/filings/0001022321-25-000055.md) | [48.6](/filings/0001022321-25-000062.md) | [13.5 d](/filings/0001022321-26-000008.md) | [22.0](/filings/0001022321-26-000017.md) | [67.7](/filings/0001022321-26-000023.md) | [78.6](/filings/0001022321-25-000062.md) | [89.9 d](/filings/0001022321-26-000008.md) | [76.6](/filings/0001022321-26-000017.md) | [105](/filings/0001022321-26-000023.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.6](/filings/0001022321-24-000095.md) | [(1.3) d](/filings/0001022321-26-000008.md) | [0.8](/filings/0001022321-25-000047.md) | [(0.0)](/filings/0001022321-25-000055.md) | [(0.9)](/filings/0001022321-25-000062.md) | [1.9 d](/filings/0001022321-26-000008.md) | [0.1](/filings/0001022321-26-000017.md) | [0.3](/filings/0001022321-26-000023.md) | [0.3](/filings/0001022321-25-000062.md) | [0.1 d](/filings/0001022321-26-000008.md) | [0.1](/filings/0001022321-26-000017.md) | [0.2](/filings/0001022321-26-000023.md) |
| Net income | $m | [58.1](/filings/0001022321-24-000095.md) | [12.0 d](/filings/0001022321-26-000008.md) | [11.4](/filings/0001022321-25-000047.md) | [(8.7)](/filings/0001022321-25-000055.md) | [(17.2)](/filings/0001022321-25-000062.md) | [(49.4) d](/filings/0001022321-26-000008.md) | [(469)](/filings/0001022321-26-000017.md) | [(0.4)](/filings/0001022321-26-000023.md) | [9.2](/filings/0001022321-25-000062.md) | [19.9 d](/filings/0001022321-26-000008.md) | [6.8](/filings/0001022321-26-000017.md) | [42.9](/filings/0001022321-26-000023.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001022321-24-000095.md) | not reported | [(0.09)](/filings/0001022321-25-000047.md) | [(0.25)](/filings/0001022321-25-000055.md) | [(0.32)](/filings/0001022321-25-000062.md) | not reported | [(4.06)](/filings/0001022321-26-000017.md) | [(0.12)](/filings/0001022321-26-000023.md) | [(0.05)](/filings/0001022321-25-000062.md) | not reported | [(0.06)](/filings/0001022321-26-000017.md) | [0.26](/filings/0001022321-26-000023.md) |
| Basic EPS | $ per share | [0.29](/filings/0001022321-24-000095.md) | not reported | [(0.09)](/filings/0001022321-25-000047.md) | [(0.25)](/filings/0001022321-25-000055.md) | [(0.32)](/filings/0001022321-25-000062.md) | not reported | [(4.06)](/filings/0001022321-26-000017.md) | [(0.12)](/filings/0001022321-26-000023.md) | [(0.05)](/filings/0001022321-25-000062.md) | not reported | [(0.06)](/filings/0001022321-26-000017.md) | [0.26](/filings/0001022321-26-000023.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [21.1](/filings/0001022321-23-000097.md) | [9.2](/filings/0001022321-25-000023.md) | [7.0](/filings/0001022321-24-000051.md) | [13.7](/filings/0001022321-24-000072.md) | [13.0](/filings/0001022321-24-000095.md) | [7.4](/filings/0001022321-26-000008.md) | [377](/filings/0001022321-25-000047.md) | [4.5](/filings/0001022321-25-000055.md) | [4.9](/filings/0001022321-25-000062.md) | [6.4](/filings/0001022321-26-000023.md) | [4.2](/filings/0001022321-26-000017.md) | [39.3](/filings/0001022321-26-000023.md) |
| Current assets | $m | [1,092](/filings/0001022321-23-000097.md) | [964](/filings/0001022321-25-000023.md) | [880](/filings/0001022321-24-000051.md) | [866](/filings/0001022321-24-000072.md) | [925](/filings/0001022321-24-000095.md) | [912](/filings/0001022321-26-000008.md) | [937](/filings/0001022321-25-000047.md) | [587](/filings/0001022321-25-000055.md) | [652](/filings/0001022321-25-000062.md) | [687](/filings/0001022321-26-000023.md) | [703](/filings/0001022321-26-000017.md) | [1,299](/filings/0001022321-26-000023.md) |
| Total assets | $m | [6,938](/filings/0001022321-23-000097.md) | [7,019](/filings/0001022321-25-000023.md) | [6,945](/filings/0001022321-24-000051.md) | [6,951](/filings/0001022321-24-000072.md) | [7,059](/filings/0001022321-24-000095.md) | [7,038](/filings/0001022321-26-000008.md) | [5,212](/filings/0001022321-25-000047.md) | [4,839](/filings/0001022321-25-000055.md) | [4,870](/filings/0001022321-25-000062.md) | [4,861](/filings/0001022321-26-000023.md) | [4,837](/filings/0001022321-26-000017.md) | [5,413](/filings/0001022321-26-000023.md) |
| Current liabilities | $m | [1,024](/filings/0001022321-23-000097.md) | [967](/filings/0001022321-25-000023.md) | [835](/filings/0001022321-24-000051.md) | [794](/filings/0001022321-24-000072.md) | [897](/filings/0001022321-24-000095.md) | [859](/filings/0001022321-26-000008.md) | [633](/filings/0001022321-25-000047.md) | [622](/filings/0001022321-25-000055.md) | [673](/filings/0001022321-25-000062.md) | [700](/filings/0001022321-26-000023.md) | [721](/filings/0001022321-26-000017.md) | [1,399](/filings/0001022321-26-000023.md) |
| Total liabilities | $m | [5,187](/filings/0001022321-23-000097.md) | [5,308](/filings/0001022321-25-000023.md) | [5,257](/filings/0001022321-24-000051.md) | [5,306](/filings/0001022321-24-000072.md) | [5,464](/filings/0001022321-24-000095.md) | [5,522](/filings/0001022321-26-000008.md) | [4,472](/filings/0001022321-25-000047.md) | [4,121](/filings/0001022321-25-000055.md) | [4,162](/filings/0001022321-25-000062.md) | [4,153](/filings/0001022321-26-000023.md) | [4,301](/filings/0001022321-26-000017.md) | [4,960](/filings/0001022321-26-000023.md) |
| Long-term debt | $m | [3,613](/filings/0001022321-23-000097.md) | [3,764](/filings/0001022321-25-000023.md) | [3,849](/filings/0001022321-24-000051.md) | [3,949](/filings/0001022321-24-000072.md) | [4,022](/filings/0001022321-24-000095.md) | [3,728](/filings/0001022321-26-000008.md) | [3,439](/filings/0001022321-25-000047.md) | [3,108](/filings/0001022321-25-000055.md) | [3,097](/filings/0001022321-25-000062.md) | [3,047](/filings/0001022321-26-000023.md) | [3,176](/filings/0001022321-26-000017.md) | [3,104](/filings/0001022321-26-000023.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001022321-26-000023.md) | not reported | [99.5](/filings/0001022321-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [141 d](/filings/0001022321-24-000095.md) | [125 d](/filings/0001022321-26-000008.md) | [126](/filings/0001022321-25-000047.md) | [105 d](/filings/0001022321-25-000055.md) | [87.3 d](/filings/0001022321-25-000062.md) | [74.0 d](/filings/0001022321-26-000008.md) | [24.8](/filings/0001022321-26-000017.md) | [47.0 d](/filings/0001022321-26-000023.md) | [70.3 d](/filings/0001022321-25-000062.md) | [111 d](/filings/0001022321-26-000008.md) | [81.7](/filings/0001022321-26-000017.md) | [181 d](/filings/0001022321-26-000023.md) |
| Capital expenditure | $m | [148 d](/filings/0001022321-24-000095.md) | [224 d](/filings/0001022321-26-000008.md) | [174](/filings/0001022321-25-000047.md) | [172 d](/filings/0001022321-25-000055.md) | [120 d](/filings/0001022321-25-000062.md) | [121 d](/filings/0001022321-26-000008.md) | [81.6](/filings/0001022321-26-000017.md) | [54.6 d](/filings/0001022321-26-000023.md) | [27.0 d](/filings/0001022321-25-000062.md) | [23.8 d](/filings/0001022321-26-000008.md) | [26.1](/filings/0001022321-26-000017.md) | [27.1 d](/filings/0001022321-26-000023.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001022321-26-000008.md) | not reported | not reported | not reported | [0.0 d](/filings/0001022321-26-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [123](/filings/0001022321-23-000097.md) | [123](/filings/0001022321-24-000051.md) | [123](/filings/0001022321-24-000072.md) | [123](/filings/0001022321-24-000095.md) | [122](/filings/0001022321-25-000047.md) | [122](/filings/0001022321-25-000055.md) | [122](/filings/0001022321-25-000062.md) | [122](/filings/0001022321-26-000017.md) | [122](/filings/0001022321-26-000023.md) | [122](/filings/0001022321-25-000062.md) | [122](/filings/0001022321-26-000017.md) | [122](/filings/0001022321-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 88,650,988 at 2014-02-24, from the cover of the [10-K filed 2014-02-27](/filings/0001022321-14-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.